The Effect of Huel on Markers of Inflammation
- Conditions
- 4 Weeks Supplementation of Huel Ready to Eat Foods
- Registration Number
- NCT07049874
- Lead Sponsor
- Newcastle University
- Brief Summary
This project will assess the effect of Huel on markers of gastrointestinal inflammation of 30 generally healthy individuals. The aim is to identify any changes in the markers of inflammation status of volunteers in any of the 9 markers to be monitored. Inflammation status will be measured at the start of the study, after one week of their habitual diets and again after four weeks of consuming two ready to drink Huel products per day, one Hot \& Savoury Huel (grain-based option only) and the remainder of their calorie intake to be made up of Huel Powder (v3.1).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Generally healthy Aged 18 years and over Non-pregnant, Non-lactating non-smoking
Smoker Pregnant Lactating BMI >30 Food allergy Disordered eating Disorder which could impact the study outcomes Medications which could impact the study outcomes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method C-Reactive protein baseline and after 4 weeks supplementation neutrophils baseline and after 4 weeks supplementation TNF-alpha baseline and after 4 weeks supplementation IL-10 baseline and after 4 weeks supplementation IL-6 baseline and after 4 weeks supplementation
- Secondary Outcome Measures
Name Time Method arachidonic acid baseline and after 4 weeks supplementation linoleic acid baseline and after 4 weeks supplementation Body mass baseline and after 4 weeks supplementation Waist cercumference baseline and after 4 weeks supplementation alpha-linoleic acid baseline and after 4 weeks supplementation eicosapentaenoic acid baseline and after 4 weeks supplementation Body Mass Index baseline and after 4 weeks supplementation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Faculty of Medical Sciences
🇬🇧Newcastle Upon Tyne, Tyne and wear, United Kingdom
Faculty of Medical Sciences🇬🇧Newcastle Upon Tyne, Tyne and wear, United Kingdom